Prime Highlights
- SuperMeat has raised $3.5 millionto support the launch of its cultivated chicken in Europe.
- The funding marks a major step toward bringing lab-grown chicken to commercial markets.
Key Facts
- Agronomics led the round with a $2 million investmentthrough cash and newly issued shares.
- The funding is part of a larger raise aimed at supporting large-scale production and market rollout.
Background
Israeli food tech company SuperMeat has raised $3.5 million in fresh funding to help launch its cultivated chicken products in Europe. This marks another key step toward bringing large-scale, lab-grown chicken to the market.
The new investment round is led by existing backer Agronomics, which has put in $2 million through a combination of cash and new shares. Other returning investors, including Milk and Honey Ventures, also took part. The company has now raised $18.5 million in total, as it works toward a broader $4.5 million SAFE round, which will convert into equity at a future financing event at a discount.
Agronomics executive chair Jim Mellon said the company’s progress demonstrates both strong commercial potential and major technological advances in alternative protein production. He added that cultivated meat represents a shift toward cleaner and more sustainable food manufacturing.
The company has focused heavily on reducing production costs, eliminating expensive animal-based growth ingredients and replacing them with affordable alternatives. It now reports media costs below 50 cents per litre and production expenses of $11.80 per pound at industrial scale, reaching price levels similar to premium traditional chicken.
A life-cycle study conducted by CE Delft found that SuperMeat’s system could cut carbon emissions by around 50% compared with conventional poultry farming. When fully scaled, the company expects to manufacture more than six million pounds of cultivated chicken annually, using significantly less land than traditional agriculture.
While the United States has been a key market, the latest funding places Europe at the centre of SuperMeat’s expansion efforts. The company is a founding member of Cellular Agriculture Europe and has partnerships with major industry players, including Germany’s PHW Group and Swiss retailer Migros. It is also collaborating with biotech firm Stämm to bring its product to market by 2026.
SuperMeat CEO Ido Savir said the new investment will support the transition from successful pilot-scale production to commercial launch. “We have made significant progress in making cultivated chicken commercially viable, and we are now focused on turning that achievement into real-world market availability,” he said.
The company continues to engage with regulators across the US, Europe and Asia as it works toward approval and widespread distribution of its cultivated chicken products.
Read Also : Acclaimed London Eatery Whyte’s Brings Signature Flavours to Glasgow’s West Side Tavern
